期刊文献+

肝癌微血管密度、微血管面积和Piezo1的表达与微血管侵犯的相关性 被引量:7

Correlation between microvascular density,microvascular area,Piezo1 expression and microvascular invasion in hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨肝癌组织中微血管密度(microvascular density,MVD)、微血管面积(microvascular area,MVA)以及Piezo1的表达水平预测肝癌微血管侵犯(microvascular invasion,MVI)的临床价值。方法:应用免疫组织化学方法检测38例病理证实为肝癌患者的肝癌组织的CD34以及Piezo1的表达情况,计算基于CD34染色的MVD和MVA,分析MVI与MVD,MVA以及Piezo1因子的表达水平的相关性。结果:38例肝癌中,13例有微血管侵犯,定义MVI(+)组,25例无微血管侵犯,定义MVI(.)组。MVI(+)组的MVA及MVD均高于MVI(.)组,两组间差异有统计学意义(P=0.007,P=0.011)。MVD和MVA联合预测MVI的敏感性和特异性为100%和64%,较单一指标效能高。Piezo1在肝癌MVI(+)组阳性率高于MVI(.)组,两组间差异有统计学意义(P=0.032)。结论:MVD,MVA以及Piezo1的表达水平均与肝癌MVI具有一定的相关性,可以作为辅助诊断微血管侵犯的指标,Piezo1可以作为潜在的限制MVI的治疗靶点。 Objective: To investigate the clinical value of microvascular density (MVD), microvascular area (MVA) and the expression of Piezol in predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC). Methods: Immunohistochemical method was applied to detect the expression of CD34 and Piezol of 38 pathologically confirmed HCC for 38 patients, MVD and MVA were measured based on CD34 staining. Thecorrelations between the expression level of Piezol, MVD, MVA and MVI were analyzed. Results: Thirteen in 38 cases were presented with MVI, defined as MVI (+) group, 25 in 38 cases were absence of MV[, defined as MVI (-) group, qhe MVA and MVD were significantly higher in MVI (+) group (P=0.007, P=0.011; respectively) than in MV/(-) group. MVD combined with/VIVA achieved a sensitivity of 100% and a specificity of 64% in predicting MVI of HCC, which was higher than single index. The expression level of Piezol was significantly higher in the MVI (+) group than in the MVI (-) group (P=0.032). Conclusion: MVD, MVA and the expression level of Piezo 1 are significantly correlated with MVI which can be used as surrogate markers of MVI, Piezo 1 may be a novel therapy target for restraining MVI.
出处 《临床与病理杂志》 2017年第8期1593-1600,共8页 Journal of Clinical and Pathological Research
基金 中南大学湘雅医院临床科研基金(2014L05)~~
关键词 肝癌 微血管侵犯 微血管密度 微血管面积 Piezo1 hepatocellular carcinoma microvascular invasion microvascular density microvascular area Piezo 1
  • 相关文献

参考文献2

二级参考文献18

  • 1曾达武,刘豫瑞.血管内皮生长因子在肝癌中的表达[J].福建医科大学学报,2005,39(B08):44-46. 被引量:1
  • 2陈淑勤,高凌云,汪晓军,袁芳平.肝细胞癌p53、bcl-2蛋白及微血管密度的检测及意义[J].福建医科大学学报,2007,41(3):211-213. 被引量:1
  • 3Tung-Ping P R,Fan S T,Wong J.Risk factors,prevention and management of postoperative recurrence after resection of hepatocellular carcinoma[J].Ann Surg,2000,232:10-24.
  • 4Esnaola N F,Lauwers Gy,Mirza N Q,et al.Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation[J].Gastrointest Surg,2002,6:224-232.
  • 5Valerie P,Francoise D,Delphine D,et al.Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases[J].Hepatology,2005,41(1):40-47.
  • 6Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma[J].J Natl Cancer lnst,2004,84(24):1875.
  • 7Lauwers G Y,Terrls B,Balis U J,et al.International cooperative study group on hepatoellular carcinoma.Prognostic histologic Indicators of curatively resected hepatocellular carcinomas;a multi-institutional analysis of 425 patients with definition of a histologic prognostic index[J].Surg Parhol,2002,26:25-34.
  • 8Grizzi F,Franceschini B,Hamrick C,et al.Usefulness of cancer-testis antigens as biomarkers forthe diagnosis and treatment of hepatocellular carcinolma[J].Transl Med,2007,23:3.
  • 9Liu L P,Liang H F,Chen X P,et al.The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs[J].Cancer Invest,2010,28(5):443-451.
  • 10Nagaoka S,Yoshida T,Akiyoshi J,et al.The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptorl predicts the prognosis of hepatocellular carcinoma[J].Oncol Rep,2010,23(6):1647-1654.

共引文献40

同被引文献39

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部